Holen Sie sich die Stockscreener-App
172.24
0.93%
-1.61
Handel nachbörslich:
172.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$173.85
Offen:
$171.71
24-Stunden-Volumen:
4.10M
Relative Volume:
2.18
Marktkapitalisierung:
$20.51B
Einnahmen:
$6.28B
Nettoeinkommen (Verlust:
$703.80M
KGV:
30.33
EPS:
5.6784
Netto-Cashflow:
$1.14B
1W Leistung:
+0.98%
1M Leistung:
-5.56%
6M Leistung:
-17.38%
1J Leistung:
-34.84%
1-Tages-Spanne:
$171.36
$176.81
1-Wochen-Bereich:
$169.49
$178.80
52-Wochen-Spanne:
$166.02
$281.03
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
172.24 | 20.70B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
178.68 | 23.73B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
77.84 | 9.44B | 11.41B | 832.81M | 933.44M | 6.728 |
FCN
Fti Consulting Inc
|
168.05 | 5.24B | 3.79B | 270.87M | 93.60M | 8.2561 |
HURN
Huron Consulting Group Inc
|
132.10 | 2.18B | 1.70B | 105.04M | 162.31M | 5.8476 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Fortgesetzt | BofA Securities | Buy |
| 2025-10-13 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-01 | Eingeleitet | Seaport Research Partners | Neutral |
| 2025-07-10 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-06-23 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Kornitzer Capital Management Inc. KS Cuts Stock Position in Equifax, Inc. $EFX - MarketBeat
Oppenheimer Asset Management Inc. Grows Stock Holdings in Equifax, Inc. $EFX - MarketBeat
Equifax, Inc. (NYSE:EFX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Equifax CEO, CFO to webcast fireside chats at June events - Stock Titan
Equifax Announces Participation in Upcoming Investor Conferences - PR Newswire
Equifax : How Loan Stacking Can Impact Lenders and Consumers - marketscreener.com
Equifax, Inc. (NYSE:EFX) Short Interest Up 15.0% in April - MarketBeat
EFX Stock Price, Quote & Chart | EQUIFAX INC (NYSE:EFX) - ChartMill
Q3 2025 Equifax Inc Earnings Call Transcript - GuruFocus
Q4 2025 Equifax Inc Earnings Call Transcript - GuruFocus
Equifax Ataeva Launch Targets Lender Analytics As Shares Trade Below Value - Yahoo Finance
Equifax Inc (NYSE:EFX) Shines in Quality Investing Screen with Strong Growth and Profitability - ChartMill
Equifax Inc. Stock (US2944291051): Q1 2026 Earnings Release Expected Today - AD HOC NEWS
Vanguard (NYSE: EFX) reports 9.02M shares, 7.47% stake in Equifax - Stock Titan
Citizens Bank Data Breach: Financial Information Exposed - Claim Depot
(EFX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Here's Why Equifax (EFX) is a Strong Growth Stock - Yahoo Finance
Equifax, Inc. $EFX Shares Sold by Vanguard Group Inc. - MarketBeat
Equifax (EFX) Q1 2026 earnings summary - Quartr
Insider Selling: Equifax (NYSE:EFX) CEO Sells 37,791 Shares of Stock - MarketBeat
5 Must-Read Analyst Questions From Equifax’s Q1 Earnings Call - Yahoo Finance
Equifax (NYSE: EFX) CEO sells shares under Rule 10b5-1 trading plan - Stock Titan
Equifax (EFX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Equifax (EFX) is a top-ranked value stock: Should you buy? - MSN
5-Day Sell-Off Sends Equifax Stock Down -14% - Trefis
Equifax Stock 5-Day Losing Spree: Stock Falls 14% - Trefis
Morgan Stanley Trims Equifax Price Target to $243 From $244, Maintains Overweight Rating - marketscreener.com
Pictet Asset Management Holding SA Buys 224,073 Shares of Equifax, Inc. $EFX - MarketBeat
Equifax (NYSE:EFX) Price Target Cut to $195.00 by Analysts at BNP Paribas Exane - MarketBeat
BNP Paribas Adjusts Price Target on Equifax to $195 From $210, Maintains Neutral Rating - marketscreener.com
Equifax flagged a new type of fraud that’s slipping past every lender - thestreet.com
International Markets and Equifax (EFX): A Deep Dive for Investors - Yahoo Finance
Needham Maintains Equifax(EFX.US) With Buy Rating, Maintains Target Price $265 - Moomoo
EFX Reiterated by Needham -- Price Target Maintained at $265 - GuruFocus
Analyst Reiterates Buy on Equifax, Maintains $265 Price Target on Structural Growth Tailwinds - TipRanks
Your Credit Score Is Setting Your Car Insurance Rate — Lawmakers Want to Stop That - Benzinga
Equifax Inc at Goldman Sachs U.S. Financial Services Conference Transcript - GuruFocus
Equifax Expands Revolving Credit Facility to Boost Liquidity - The Globe and Mail
Total debt per share of Equifax Inc. – BMV:EFX - TradingView
Equifax Inc. Amends $1.5 Billion Credit Agreement – Key Terms, Lenders, and Financial Covenants Explained - Minichart
Equifax, Inc. $EFX Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Equifax Incenters fourth amendment to credit agreement on April 23, 2026 - marketscreener.com
Equifax amends credit facility, increases commitments to $2 billion By Investing.com - Investing.com South Africa
Equifax amends credit facility, increases commitments to $2 billion - Investing.com
Equifax Expands Revolving Credit Facility to $2 Billion, Extends Maturity to 2029 With JPMorgan - TradingView
Equifax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Equifax (NYSE: EFX) lifts revolver to $2B and extends 2029 maturity - Stock Titan
Equifax (NYSE: EFX) affiliate files Form 144 to sell 37,791 shares - Stock Titan
Should You Buy Equifax Stock? - Trefis
Jefferies Adjusts Price Target on Equifax to $200 From $220, Maintains Buy Rating - marketscreener.com
Equifax exposes AI fraud threat hitting modern business - thestreet.com
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.34%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):